Form 4: Repare Therapeutics CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Repare Therapeutics CEO, Lloyd Mitchell Segal, sold shares to cover tax obligations related to the vesting of restricted stock units.
Summary
- On March 12, 2025, Lloyd Mitchell Segal, the President and CEO of Repare Therapeutics Inc., sold 21,179 common shares at a price of $1.14 per share.
- The sale was executed to satisfy the reporting person's tax withholding obligation in connection with the vesting and settlement of restricted stock units.
- Following the transaction, Segal directly owns 124,394 common shares and indirectly owns 107,558 common shares through Arvala Inc., where he is the sole stockholder.
Sentiment
Score: 6
Explanation: The document describes a routine transaction (selling shares to cover tax obligations). It doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations are a common practice among executives receiving equity compensation. This transaction is a routine part of executive compensation and doesn't necessarily indicate a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 03/12/2025 | Date of the transaction (sale of shares). |
| 03/14/2025 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.